v3.26.1
Share-based Compensation (Tables)
6 Months Ended
Jun. 30, 2026
2019 Incentive Award Plan  
Share-based Compensation  
Schedule of stock option activity

  ​ ​ ​

  ​ ​ ​

Weighted

Average

Number of

Exercise

Shares

Price

Outstanding, January 1, 2026

47,955

$

720.00

Options granted

 

Options forfeited

 

Outstanding, June 30, 2026

 

47,955

$

720.00

Exercisable, June 30, 2026

 

47,516

$

720.00

Summary of restricted stock units activity

  ​ ​ ​

  ​ ​ ​

Weighted

Average

Number of

Grant Date

Shares

Fair Value

Outstanding, January 1, 2026

 

9,351

$

780.48

Granted

 

 

Vested

 

(1,639)

Forfeited

Outstanding, June 30, 2026

 

7,712

$

780.48

AEON Biopharma Inc 2023 Incentive Award Plan  
Share-based Compensation  
Schedule of stock option activity

  ​ ​ ​

  ​ ​ ​

Weighted

Average

Number of

Exercise

Shares

Price

Outstanding, January 1, 2026

 

51,016

$

242.14

Options granted

 

Options forfeited

 

Outstanding, June 30, 2026

 

51,016

$

242.14

Exercisable, June 30, 2026

 

45,160

$

169.94

Summary of restricted stock units activity

  ​ ​ ​

  ​ ​ ​

Weighted

Average

Number of

Grant Date

Shares

Fair Value

Outstanding, January 1, 2026

 

14,215

$

60.05

Granted

 

12,041,479

0.92

Vested

 

(2,278,801)

 

Forfeited

 

Outstanding, June 30, 2026

 

9,776,893

$

0.94

2025 Employment Inducement Incentive Award Plan  
Share-based Compensation  
Schedule of stock option activity

  ​ ​ ​

  ​ ​ ​

Weighted

Average

Number of

Exercise

Shares

Price

Outstanding, January 1, 2026

 

59,034

$

0.41

Options granted

 

Options forfeited

 

 

Outstanding, June 30, 2026

 

59,034

0.41

Exercisable, June 30, 2026

 

14,758

$

0.41

Summary of restricted stock units activity

  ​ ​ ​

  ​ ​ ​

Weighted

Average

Number of

Grant Date

Shares

Fair Value

Outstanding, January 1, 2026

 

672,141

$

0.65

Granted

 

990,566

0.89

Vested

 

(69,995)

 

Forfeited

 

Outstanding, June 30, 2026

 

1,592,712

$

0.78